Danaher | DHR - Stammkapital





Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Agilent USD 282.22M 478K 2026-03
Align Technology USD 71.62M 133K 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio Techne USD 156.45M 703K 2026-03
Bio-Rad Laboratories USD 26.99M 18K 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Bruker USD 152.22M 282K 2026-03
Charles River Laboratories USD 48.17M 1.05M 2026-03
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 200.3M 700K 2026-03
Edwards Lifesciences USD 580.7M 0 2025-12
ESCO Technologies USD 25.9M 67K 2025-12
Fortive USD 305.6M 7.8M 2026-03
Henry Schein USD 114.42M 1.35M 2026-03
Illumina USD 151.91M 893K 2026-03
Intuitive Surgical USD 355.17M 674K 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Keysight Technologies USD 171M 800K 2026-03
Laboratory Of America USD 82.3M 100K 2026-03
Medtronic USD 1.28B 1.38M 2025-12
Mettler Toledo International USD 20.25M 179.94K 2026-03
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Quidel USD 67.9M 0 2025-12
Repligen USD 56.4M 74K 2026-03
Revvity USD 111.8M 1.57M 2026-03
Roper Industries USD 102.4M 4.2M 2026-03
Stryker USD 382.98M 584K 2026-03
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Waters USD 98.17M 89K 2026-03
Zimmer Biomet Holdings USD 195.5M 2.68M 2026-03